hCAI/II-IN-3, hCA I/II inhibitor

17α-Thevebioside, bioactive compound

Colesevelam hydrochloride (GT31-104HB; GT-31-104HB) is a bile acid sequestrant and anti-hyperlipidemic agent. It acts by binding to bile acids in the gut, thus inhibiting bile acid reabsorption, leading to increased bile acid synthesis and reduced cholesterol levels in patients with cholestatic pruritus and Crohn’s disease.

6-Methylnicotinamide, endogenous metabolite

hCAI/II-IN-1, human carbonic anhydrase I and II (hCA I/II) inhibitor

(S)-1-(4-Hydroxy-2,2-dimethylchroman-6-yl)ethanone, chiral alcohol

hCAI/II-IN-5, hCA I and hCA II (human carbonic anhydrase isoenzymes I and II) inhibitor

hCAI/II-IN-4, hCA I/II inhibitor

Potassium phosphate monobasic, biological assay buffers

NMDA receptor antagonist 4, NMDAR blocker